Inhibition of Adenosine Deaminase to Increase the Antitumor Activity of Adenine Nucleoside Analoguesa
- 1 October 1985
- journal article
- clinical trial
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 451 (1) , 150-159
- https://doi.org/10.1111/j.1749-6632.1985.tb27106.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Adenosine‐resistant chinese hamster fibroblast variants with hyperactive adenosine‐deaminase: An analysis of the protection against exogenous adenosine afforded by increased activity of the deamination pathwayJournal of Cellular Physiology, 1984
- Effect of 2′-deoxycoformycin on the inhibition of deoxyribonucleic acid synthesis by 9-β-d-arabinofuranosyladenine 5′-triphosphateBiochemical Pharmacology, 1982
- Inhibitors of adenosine deaminasePharmacology & Therapeutics, 1982
- The clinical pharmacology of the adenosine deaminase inhibitor 2?-deoxycoformycinCancer Chemotherapy and Pharmacology, 1980
- Effect of 2′-deoxycoformycin on the biologic half-life of 9-β-d-arabinofuranosyladenine 5′-triphosphate in CHO cellsBiochemical Pharmacology, 1979
- Comparison of the activity of 2′-deoxycoformycin and erythro-9-(2-hydroxy-3-nonyl)adenine in vivoBiochemical Pharmacology, 1979
- 5-azacytidine and arabinosyl adenine for the treatment of acute leukemiaLeukemia Research, 1977
- Adenosine deaminase activity in peripheral blood cells of patients with haematological malignanciesBritish Journal of Cancer, 1976
- Adenosine deaminase activity in leukaemiaBritish Journal of Cancer, 1975
- Alterations in enzyme activity in tumors and the implications for chemotherapyAdvances in Enzyme Regulation, 1970